Clearside Biomedical is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space, or SCS. Co.'s SCS injection platform, utilizing its proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Co.'s SCS injection platform can be used in conjunction with existing drugs designed for delivery to the SCS, therapies and future therapeutic inventions. We show 32 historical shares outstanding datapoints in our CLSD shares outstanding history coverage, used to compute CLSD market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CLSD market cap history over the course of time is important for investors
interested in comparing CLSD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CLSD versus a peer is one thing; comparing
CLSD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CLSD can fluctuate over the course of history.
With this page we aim to empower investors researching CLSD by allowing them to research the CLSD market cap history. |
Free CLSD Email Alerts:
Video: The Importance of Market Cap
